刘建建

建建 刘 is currently the National MSL Manager at Novartis, specializing in central nervous system and rare diseases. They previously held the same title at 诺华 from 2020 to 2021 and served as an MSL expert for Benlysta at 葛兰素史克公司 in 2020. Prior to their roles in the pharmaceutical industry, 建建 worked as an attending physician and inpatient doctor at 山东省交通医院 from 2009 to 2013, where they coordinated numerous academic congresses and gained clinical experience in chronic kidney diseases. Between 2013 and 2017, they advanced from an executive MSM to an MSM M at 百时美施贵宝, demonstrating strong leadership and talent development capabilities throughout their career.